J. Milner et al., The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase, ONCOGENE, 19(38), 2000, pp. 4441-4445
A substantial proportion of familiar breast cancers have mutations within t
he BRCA2 gene. The product of this gene has been implicated in DNA repair a
nd in the regulation of transcription. We have previously identified at the
amino-terminus of BRCA2 a transcriptional activation domain whose importan
ce is highlighted by the presence of predisposing mutations and in-frame de
letions in breast cancer families. This activation domain shows sequence si
milarity to a region of c-Jun which has been defined as a binding site for
the c-Jun N-terminal kinase, Here, we show that the analogous region in BRC
A2 is also a binding site for a cellular kinase, although this kinase is di
stinct from JNK, The BRCA2 associated enzyme Is able to phosphorylate resid
ues within the BRCA2 activation domain. Consistent with this observation, w
e find that the activation domain of BRCA2 is phosphorylated in vivo. Our r
esults indicate that the BRCA2 activation domain possesses a binding site f
or a kinase that may regulate BRCA2 activity by phosphorylation.